Literature DB >> 21134454

Transmission of varicella vaccine virus to a non-family member in China.

Lin Gan1, Mingli Wang, Sen Yang, Anne A Gershon, Jason J Chen.   

Abstract

A 23-year-old teacher presented to hospital with a mild case of varicella. VZV vaccine strain vOka that resembles Varilrix but not Varivax or Biken strains was isolated from the skin lesion of the patient and was identified by single nucleotide polymorphism (SNP) analysis. The teacher denied having varicella vaccine before. Retrospective analysis suggests the transmission came from a pupil who developed zoster 13 months after varicella vaccine Varilrix. This is the first report in China in which an adult with varicella was attributable to vaccine virus and the 6th report of transmission of vaccine virus to a susceptible adult around the world.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21134454      PMCID： PMC5381808          DOI： 10.1016/j.vaccine.2010.11.071

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  10 in total

1.  Chickenpox attributable to a vaccine virus contracted from a vaccinee with zoster.

Authors:  P A Brunell; T Argaw
Journal:  Pediatrics       Date:  2000-08       Impact factor: 7.124

Review 2.  The current status of live attenuated varicella vaccine.

Authors:  A A Gershon
Journal:  Arch Virol Suppl       Date:  2001

3.  Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother.

Authors:  M B Salzman; R G Sharrar; S Steinberg; P LaRussa
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

4.  Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR.

Authors:  V N Loparev; T Argaw; P R Krause; M Takayama; D S Schmid
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

5.  Secondary transmission of varicella vaccine virus in a chronic care facility for children.

Authors:  Richard Grossberg; Rafael Harpaz; Elena Rubtcova; Vladimir Loparev; Jane F Seward; D Scott Schmid
Journal:  J Pediatr       Date:  2006-06       Impact factor: 4.406

6.  The postmarketing safety profile of varicella vaccine.

Authors:  R G Sharrar; P LaRussa; S A Galea; S P Steinberg; A R Sweet; R M Keatley; M E Wells; W P Stephenson; A A Gershon
Journal:  Vaccine       Date:  2000-11-22       Impact factor: 3.641

7.  Complete DNA sequences of two oka strain varicella-zoster virus genomes.

Authors:  Sueli L Tillieux; Wendy S Halsey; Elizabeth S Thomas; John J Voycik; Ganesh M Sathe; Ventzislav Vassilev
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

8.  Genotyping of clinical varicella-zoster virus isolates collected in China.

Authors:  Jingjing Liu; Mingli Wang; Lin Gan; Sen Yang; Jason Chen
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

9.  An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.

Authors:  Mark Quinlivan; Anne A Gershon; Sharon P Steinberg; Judith Breuer
Journal:  J Med Virol       Date:  2005-01       Impact factor: 2.327

10.  Transmission of varicella vaccine virus, Japan.

Authors:  Taketo Otsuka; Yasuyuki Gomi; Naoki Inoue; Makoto Uchiyama
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883
  10 in total
  6 in total

1.  Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster.

Authors:  Mark L Quinlivan; Nancy J Jensen; Kay W Radford; D Scott Schmid
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

Review 2.  Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic Review.

Authors:  Mona Marin; Jessica Leung; Anne A Gershon
Journal:  Pediatrics       Date:  2019-09       Impact factor: 7.124

Review 3.  Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

4.  Genetic analysis of clinical VZV isolates collected in China reveals a more homologous profile.

Authors:  Longfeng Jiang; Lin Gan; Jason Chen; Mingli Wang
Journal:  Biomed Res Int       Date:  2013-05-27       Impact factor: 3.411

5.  Infected peripheral blood mononuclear cells transmit latent varicella zoster virus infection to the guinea pig enteric nervous system.

Authors:  Lin Gan; Mingli Wang; Jason J Chen; Michael D Gershon; Anne A Gershon
Journal:  J Neurovirol       Date:  2014-06-26       Impact factor: 3.739

6.  Effects of Shield1 on the viral replication of varicella‑zoster virus containing FKBP‑tagged ORF4 and 48.

Authors:  Shuying Li; Zhanjun Liu; Ji Li; Aihua Liu; Lihua Zhu; Kui Yu; Ke Zhang
Journal:  Mol Med Rep       Date:  2017-11-06       Impact factor: 2.952
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.